Clinical Trial Update: Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CMV RNA-pulsed dendritic cells in pediatric and young adult patients with recurrent malignant glioma and related brain tumors; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Brain Tumor Recurrent
• Glioblastoma
• Glioblastoma Multiforme
• Malignant Glioma
• Medulloblastoma

Drugs mentioned

• CMV RNA-pulsed dendritic cells

Snippet

Sponsor: Gary Archer Ph.D. | Conditions: Glioblastoma, Malignant Glioma | Phase 1 | Status: COMPLETED | Results posted: 2021-01-28